Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
about
The Mechanism of and Preventive Therapy for Stroke in Patients with Atrial FibrillationNovel oral anticoagulants and the 73rd anniversary of historical warfarinHow to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillationThe HAS-BLED Score for Predicting Major Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: A Systematic Review and Meta-analysisAntithrombotic management of atrial fibrillation in the elderlyStroke prevention in older adults with atrial fibrillationManaging anticoagulation for atrial fibrillation: current issues and future strategiesAn evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillationSystematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Asian strategy for stroke prevention in atrial fibrillationNon-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementationAtrial fibrillation in women: treatmentAddressing Disparities in Stroke Prevention for Atrial Fibrillation: Educational Opportunities.Use of an interdisciplinary, participatory design approach to develop a usable patient self-assessment tool in atrial fibrillationPersonalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.Benefits of once-daily dosing with non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.Correlation between trough plasma dabigatran concentrations and estimates of glomerular filtration rate based on creatinine and cystatin C.Outcomes associated with warfarin use in older patients with heart failure and atrial fibrillation and a cardiovascular implantable electronic device: findings from the ADHERE registry linked to Medicare claims.Edoxaban: an update on the new oral direct factor Xa inhibitor.Safe use of antithrombotics for stroke prevention in atrial fibrillation: consideration of risk assessment tools to support decision-makingStroke and bleeding risk in atrial fibrillation.Expanding use of new oral anticoagulantsRate versus rhythm control in atrial fibrillation.Approach to the new oral anticoagulants in family practice: part 1: comparing the options.Clinical implications of recent trials on anticoagulation in patients with atrial fibrillation.Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questionsAntiarrhythmic agents and the risk of malignant neoplasm of liver and intrahepatic bile ducts.The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society.Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortalityParoxysmal atrial fibrillation and the hazards of under-treatmentImpact of Rural Residence on Warfarin Use and Clinical Events in Patients with Non-Valvular Atrial Fibrillation: A Canadian Population Based Study.Managing atrial fibrillation.Incident atrial fibrillation in the emergency department in Ontario: a population-based retrospective cohort study of follow-up careThe use of dronedarone for recurrent ventricular tachycardia: a case report and review of the literature.Long-term stroke rates after catheter ablation or antiarrhythmic drug therapy for atrial fibrillation: a meta-analysis of randomized trials.Cardiac CT angiography for device surveillance after endovascular left atrial appendage closure.Volume Matters: Improved Outcomes for Patients Presenting to High-Volume Emergency Departments with Atrial Flutter and Fibrillation.Persistence of non-vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single-center observational study.
P2860
Q26747263-E8597EFC-738C-4C42-97D8-FBEB1412ECB0Q26771544-C78DDA73-0AB6-4EE2-89A0-F069A8FD5D22Q26776413-E246E336-E7B4-4940-9065-E5EBD098F0B8Q26784497-447B1DF5-5124-40DA-8F90-9E62F22B2CB1Q26827113-D3508204-B5A2-4F79-BA79-F2FE37CB0694Q26830227-01EA3F03-ED13-4B85-A7A8-3C0DAB9B1810Q26991728-E4C38F5A-005B-469A-9178-43B7E9CA28E8Q27027953-54523BD0-E15D-4813-BC76-BDE8DF8545B6Q27337981-FB38BDFA-A11D-48A3-84A3-6A3E98D8DD11Q27341873-B9079C0A-97B8-4BEB-9BBE-64A2A87D6027Q28072723-5569F8B7-84E6-438C-A3EA-0C4DB0B7B6A6Q28087146-02882FA1-9966-405C-8B45-9865667D7282Q30241862-4D0E49F7-3336-4F8E-B79A-0A9C2B119E53Q30300349-181D20F1-56DE-4475-85D0-3C7D44F9409BQ30557089-B665DD86-B0FB-48AA-B5BF-B88DBCB5520CQ30663685-43D527A2-97DA-4907-8F06-826ABFF8D136Q33646770-E21CC2C3-E867-438F-B0ED-02CBB976D48BQ33804810-6A94D079-7C85-4F3A-B1B8-79027EAF8005Q33828157-2B6EBA2B-49E3-4359-81BC-16054BCFA817Q33935409-C039246C-BF8D-433A-A19C-6E6E2DE3EAC5Q33949571-CA45AAA0-8A28-40D7-9D8A-B5317596095FQ34269633-35006166-9125-4BE1-A9D0-714B355779A0Q34312531-9C3464AA-FD13-4F7A-B098-2CDC6B34155DQ34328299-3D0092B4-D614-4472-9DB3-1BCC1902DA48Q34497581-06B2782C-8C18-49E9-8A8E-0AA90512673FQ34621707-E3C911EB-76FE-4ADE-BBAB-BA329503B1FFQ34641456-08640E47-3470-4941-9461-53B1175A853DQ34666269-A486B8D6-2B5A-4A42-A0F9-F8D9AFF69740Q34973496-4B710BBD-8F77-47AB-818B-332DF39E0C72Q35028638-494B1670-A7B0-4A93-B0CD-91627266CBCBQ35587911-B6B34079-24C7-41C0-B3DE-B75ACFDB3AE8Q35784686-7E3E8972-D028-40BE-84AE-0B30D8A1BB4DQ35806598-AAF47A05-1746-4BD6-AF16-D3ADC8D1CD79Q35900515-FD445C02-1F20-476D-9C2B-C340ADA71CECQ36045899-D21EDA0A-DFB3-469A-8A2C-00FBD11AE011Q36086657-CA2B138F-C3CE-493D-B0AE-9BAEC7203135Q36162187-57DEFEF1-CFD6-47B4-B745-17EABC665E79Q36172197-F1FB3C8D-4636-4E96-B69F-A33EA290827AQ36182925-51C66A42-872E-467A-AD96-C4D05030CB1AQ36352841-0332CC9D-64D8-4DC4-BF3F-D71F845AAE7E
P2860
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@en
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@nl
type
label
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@en
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@nl
prefLabel
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@en
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@nl
P2093
P1476
Focused 2012 update of the Can ...... ntion and rate/rhythm control.
@en
P2093
Allan C Skanes
Anne M Gillis
Atul Verma
Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee
Jeff S Healey
John A Cairns
L Brent Mitchell
M Sean McMurtry
Paul Dorian
Stanley Nattel
P304
P356
10.1016/J.CJCA.2012.01.021
P577
2012-03-01T00:00:00Z